-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the official website of NMPA shows that Dongyang Pharmaceutical has entered the administrative examination and approval stage with the imitation of sildenafil citrate tablets reported for production in category 4, and is expected to be approved for listing in the near future
Sildenafil Citrate is a type 5 phosphodiesterase (PDE-5) selective inhibitor developed by Pfizer for the treatment of erectile dysfunction (ED)
According to data from Meinenet, the domestic market of Sildenafil has continued to expand in recent years.
Sales of Sildenafil at Terminals of Entity Pharmacies in Chinese Cities (Unit: Ten Thousand Yuan)
Source: Mi Nei.
It is worth mentioning that in the physical pharmacy market, sildenafil is also the leading urinary system drug
2020 China's urban physical pharmacies terminal chemical urinary system drug products TOP5
Source: Mi Nei.
Sildenafil citrate tablets have been included in the third batch of centralized procurement, and 9 companies have been reviewed, including Qilu Pharmaceutical, Baiyunshan, Yangzijiang Pharmaceutical, Guangshengtang, China Resources SECCO, and Yabang Epson
Data source: Mi Neiwang database, NMPA
Note: Meinenet China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 297 cities and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
